XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(FY)Aug 31, 2024 | (Q6)Feb 29, 2024 | (FY)Aug 31, 2023 | (Q6)Feb 28, 2023 | (FY)Aug 31, 2022 | (Q6)Feb 28, 2022 | (FY)Aug 31, 2021 | (Q6)Feb 28, 2021 | (FY)Aug 31, 2020 | (Q6)Feb 29, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 17.09%322.9M | 12.25%170.76M | 15.74%275.77M | 15.46%152.13M | 21.47%238.26M | 34.52%131.76M | 25.65%196.14M | 9.87%97.94M | 12.94%156.1M | 16.10%89.15M |
Operating income | 17.09%322.9M | 12.25%170.76M | 15.74%275.77M | 15.46%152.13M | 21.47%238.26M | 34.52%131.76M | 25.65%196.14M | 9.87%97.94M | 12.94%156.1M | 16.10%89.15M |
Cost of sales | -19.73%-204.03M | -34.68%-105.88M | -24.23%-170.41M | 1.55%-78.62M | -41.15%-137.17M | -62.20%-79.85M | -36.76%-97.18M | -24.12%-49.23M | -20.43%-71.06M | -29.50%-39.66M |
Operating expenses | -19.73%-204.03M | -34.68%-105.88M | -24.23%-170.41M | 1.55%-78.62M | -41.15%-137.17M | -62.20%-79.85M | -36.76%-97.18M | -24.12%-49.23M | -20.43%-71.06M | -29.50%-39.66M |
Gross profit | 12.83%118.87M | -11.73%64.88M | 4.22%105.36M | 41.62%73.51M | 2.16%101.1M | 6.55%51.91M | 16.37%98.96M | -1.56%48.71M | 7.37%85.04M | 7.21%49.49M |
Selling expenses | -42.15%-4.25M | -67.56%-1.82M | -87.70%-2.99M | -7.64%-1.09M | 12.13%-1.59M | 5.35%-1.01M | -86.43%-1.81M | -92.59%-1.07M | -19.53%-973K | -87.46%-553K |
Administrative expenses | -0.07%-39.36M | 19.65%-19.48M | 2.89%-39.33M | -66.19%-24.24M | -38.09%-40.5M | -42.33%-14.59M | 21.01%-29.33M | 44.41%-10.25M | -301.12%-37.13M | -310.28%-18.43M |
Operating interest expense | ---- | ---- | ---- | ---- | ---6.98M | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | 341.11%7.05M | 1,119.78%4.54M | -60.08%1.6M | -110.28%-445K | 264.12%4M | 3,646.72%4.33M | -2,020.47%-2.44M | -1,116.67%-122K | -89.61%127K | -97.69%12K |
Operating profit | 27.34%82.31M | 0.81%48.13M | 15.37%64.64M | 17.47%47.74M | -14.31%56.03M | 9.01%40.64M | 38.91%65.38M | 22.19%37.28M | -33.11%47.07M | -27.16%30.51M |
Financing cost | -798.12%-62.23M | -193.02%-19.55M | ---6.93M | -55.71%-6.67M | ---- | 36.52%-4.29M | -313.97%-13.37M | ---6.75M | ---3.23M | ---- |
Share of profit from joint venture company | 90.68%-11K | ---10K | ---118K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Earning before tax | -65.15%20.07M | -30.44%28.57M | 2.79%57.59M | 12.96%41.07M | 7.71%56.03M | 19.08%36.35M | 18.65%52.01M | 0.07%30.53M | -37.69%43.84M | -27.16%30.51M |
Tax | ---115K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
After-tax profit from continuing operations | -65.35%19.95M | -30.44%28.57M | 2.79%57.59M | 12.96%41.07M | 7.71%56.03M | 19.08%36.35M | 18.65%52.01M | 0.07%30.53M | -37.69%43.84M | -27.16%30.51M |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -911.64%-1.48M | -203.29%-1.48M |
Earning after tax | -65.35%19.95M | -30.44%28.57M | 2.79%57.59M | 12.96%41.07M | 7.71%56.03M | 19.08%36.35M | 22.79%52.01M | 5.16%30.53M | -39.67%42.36M | -29.87%29.03M |
Minority profit | 66.67%-5K | ---5K | ---15K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | -65.35%19.96M | -30.42%28.57M | 2.82%57.6M | 12.96%41.07M | 7.71%56.03M | 19.08%36.35M | 22.79%52.01M | 5.16%30.53M | -39.67%42.36M | -29.87%29.03M |
Basic earnings per share | -65.39%0.0299 | -30.36%0.0429 | 2.86%0.0864 | 13.03%0.0616 | 7.69%0.084 | 19.00%0.0545 | -5.80%0.078 | -21.17%0.0458 | -41.03%0.0828 | 0.0581 |
Diluted earnings per share | -65.39%0.0299 | -30.36%0.0429 | 2.86%0.0864 | 13.03%0.0616 | 7.69%0.084 | 19.00%0.0545 | -5.80%0.078 | -21.17%0.0458 | -41.03%0.0828 | 0.0581 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.